Advertisement

Topics

Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars

02:33 EST 12 Nov 2017 | Topix

This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Today we will discuss an article on Neurocrine Biosciences by Stephen Ayers, titled " Buy Neurocrine, But At Cheaper Prices ."

Original Article: Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars

NEXT ARTICLE

More From BioPortfolio on "Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars"

Advertisement
Quick Search
Advertisement
Advertisement